Clarivate (NYSE:CLVT – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided EPS guidance of 0.600-0.700 for the period, compared to the consensus EPS estimate of 0.730. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.6 billion. Clarivate also updated its FY25 guidance to $0.60-$0.70 EPS.
Clarivate Trading Up 1.6 %
Shares of Clarivate stock opened at $4.84 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a 50 day simple moving average of $5.13 and a 200 day simple moving average of $5.80. Clarivate has a fifty-two week low of $4.22 and a fifty-two week high of $9.07.
Clarivate announced that its board has authorized a share repurchase program on Monday, December 16th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to reacquire up to 12.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on CLVT
Clarivate Company Profile
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Further Reading
- Five stocks we like better than Clarivate
- What Are Dividend Contenders? Investing in Dividend Contenders
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
- Why Are These Companies Considered Blue Chips?
- Gold’s Ascent: Can Miners and ETFs Take Investors to $3,000?
- When to Sell a Stock for Profit or Loss
- Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.